Agenda: Practical Solutions of Multiplex Genomic Testing in Liquid Biopsy - From Discovery to Applications

Sunday – April 10, 2022

6:00 pm Registration Open – Arrival & Welcome Drinks

6:30 pm Opening Remarks & Introduction

  • Matthew Grow Vice President, Global Marketing & Commercial Operations, Stilla Technologies

6:35 pm Interactive Discussion & Q&A: Practical Solutions of Multiplex Genomic Testing in Liquid Biopsy – From Discovery to Applications

  • Matthew Grow Vice President, Global Marketing & Commercial Operations, Stilla Technologies
  • Phillipe Mourere President & Chief Executive Officer, Stilla Technologies
  • Steven Rosen Scientific Innovation Leader in Healthcare, Wyss Institute, Harvard University
  • Rémi Dangla Founder & Chief Technology Officer, Stilla Technologies

Synopsis

• Examine the accessibility and democratization of dPCR multiplexing across labs in the LBx space
• Learn how multiplexed dPCR can help you take the next step from NGS to routine testing
• Evaluate current evidence on innovative technologies to improve detection, prognosis, disease monitoring, and drug development

7:20 pm To the bar! Networking & Drinks

Synopsis

This is an informal and exclusive networking opportunity for you to engage with business-critical solution providers, ask questions on their capabilities and strengthen connections with the most influential technology providers in the industry.

8:00 pm End of Stilla Technologies Engager